April 8, 2024
A new pilot study led by Justin Leach, PhD, aims to improve clinical trials for myasthenia gravis by incorporating the impact of emergency therapy. The Myasthenia Gravis Rare Disease Network (MGNet), Conquer MG, and Myasthenia Gravis Foundation of America are collaborating to support the project.
Dr. Leach, an assistant professor at the University of Alabama at Birmingham (UAB), will work with UAB colleagues Inmaculada Aban, PhD, and Gary Cutter, PhD, as well as Michael Benatar, MD, PhD, of the University of Miami.